These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 34576042)

  • 21. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
    Wu D
    Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.
    Zhang J; Hu Z; Horta CA; Yang J
    Semin Cancer Biol; 2023 Jan; 88():46-66. PubMed ID: 36521737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.
    Li H; Wang C; Lan L; Behrens A; Tomaschko M; Ruiz J; Su Q; Zhao G; Yuan C; Xiao X; Li B; Yan L; Wu W; Li W; Chen J; He Y; Zhang C
    Aging (Albany NY); 2021 Feb; 13(4):5197-5225. PubMed ID: 33535187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
    Pietilä M; Ivaska J; Mani SA
    Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functions of Exosomes in the Triangular Relationship between the Tumor, Inflammation, and Immunity in the Tumor Microenvironment.
    Wang T; Nasser MI; Shen J; Qu S; He Q; Zhao M
    J Immunol Res; 2019; 2019():4197829. PubMed ID: 31467934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
    Jung HY; Fattet L; Yang J
    Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy in cancer metastasis.
    Mowers EE; Sharifi MN; Macleod KF
    Oncogene; 2017 Mar; 36(12):1619-1630. PubMed ID: 27593926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.
    Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM
    Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development.
    Sahu SK; Tiwari N; Pataskar A; Zhuang Y; Borisova M; Diken M; Strand S; Beli P; Tiwari VK
    Nat Commun; 2017 Nov; 8(1):1523. PubMed ID: 29142217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
    Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
    Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
    Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
    Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
    Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
    Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
    Patel S; Alam A; Pant R; Chattopadhyay S
    Front Immunol; 2019; 10():2872. PubMed ID: 31921137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view.
    Vakili-Ghartavol R; Mombeiny R; Salmaninejad A; Sorkhabadi SMR; Faridi-Majidi R; Jaafari MR; Mirzaei H
    J Cell Physiol; 2018 Dec; 233(12):9223-9236. PubMed ID: 30078227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.